Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 35 of 47
  1. SPY002-091

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial
  2. SPY003-207

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial
  3. SPh/01/2024

    Sciencepharma Sp. z o.o

    Not applicable (submitted trial is a bioequivalence in healthy subjects)

    phase 1 other active

    1 trial
  4. SSP-002358

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  5. SSP-004184AQ

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  6. SSP-004184SS

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  7. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule completed

    1 trial
  8. SSS39

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Safety and Tolerability in Healthy Volunteers

    phase 1 small molecule active

    1 trial
  9. SSS67 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule active

    1 trial
  10. SYHA1813 oral solution (2.0g:25mg)

    Shanghai University of Traditional Chinese Medicine

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  11. SYR-472

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  12. Safety for A Phase 1, Randomized, Double-B…

    Lacuna Pharma Pty Ltd

    A Phase 1, Randomized, Double-Blind, Placebo-Controlled, First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses and Food Effect of Leucettinib-21 in Healthy Male Subjects, followed by an open single dose of Leucettinib-21 in Down Syndrome individuals, and patients with Alzheimer’s disease

    phase 1 other active

    1 trial
  13. Salmeterol

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  14. Sanchi-Tongshu Capsule (Enteric coated pellets)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial
  15. Sativex® (Treatment A)

    Jazz Pharmaceuticals Ireland Limited

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  16. Schedule A

    LEXICON PHARMACEUTICALS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  17. Scopolamine

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  18. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Healthy

    phase 1 mab completed

    1 trial
  19. Simvastatin

    Madrigal Pharmaceuticals EU Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  20. Simvastatin

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  21. Single and multiple ascending dose of ZP9830 in healthy participants

    Zealand Pharma A/S

    Autoimmune diseases

    phase 1 other active

    1 trial
  22. Soticlestat

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    4 trials
  23. Soticlestat 300 mg

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. Stelara

    Rani Therapeutics Holdings

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.